State privacy laws are reshaping how drug companies communicate with patients, Swoop chief revenue officer Katie Kerr said in a conversation with Fierce Pharma publisher Rebecca Wilmson. Kerr emphasized the need for marketers to partner with companies that prioritize privacy while still allowing outreach to all 50 states. She also emphasized that television is an important foundation for omnichannel marketing, pointing to its broad reach and ability to build patient trust before reinforcing the message through digital channels.
Carr pointed to predictive targeting as an emerging solution to the $500 billion annual challenge of patient nonadherence, offering brands an opportunity to intervene before patients drop out of treatment. Looking ahead, she predicted that major pharmaceutical companies will bring measurement internally within the next five years to enhance compliance, transparency, and competitive advantage. Watch the full interview to hear Kerr’s insights on how privacy, trust, and predictive data are redefining pharma marketing.
